The approval of Tesofensine is still under the development process, but with further UK clinical studies it is hoped that in the future it could have the following applications:

Appetite Suppression

Tesofensine exerts its appetite-suppressing effects through its action as a potent triple monoamine reuptake inhibitor. By inhibiting the reuptake of neurotransmitters like dopamine, norepinephrine, and serotonin, Tesofensine increases their levels in the synaptic cleft. This elevation in neurotransmitter activity modulates the neural circuits involved in hunger and satiety, leading to a significant reduction in appetite and food consumption (1).

The norepinephrine and dopamine receptors play key roles in regulating feelings of hunger and fullness, while serotonin influences mood and appetite control. By targeting these neurotransmitter systems, Tesofensine treatment effectively helps individuals feel satisfied with smaller amounts of food, promoting body weight loss through decreased caloric consumption.

Insulin Resistance

According to a study conducted on animal subjects, results indicated that Tesofensine had beneficial effects on glycemic control in a dose-dependent manner. Additionally, Tesofensine has been shown to decrease the insulin response in standard glucose tolerance tests significantly. This suggests that there is a reduction in the amount of insulin released in response to a sugar load (2).

Insulin resistance, the development of diabetes, cardiovascular disease, and even neurodegenerative illnesses have all been related to chronic inflammation. Tesofensine helps to shift the metabolic equilibrium and provides the body with a fighting chance against obesity by interrupting the cycle of fat deposition and inflammation that leads to both conditions.

Weight Loss

Tesofensine aids mean weight loss through its multifaceted approach, targeting appetite suppression, increased energy expenditure, and improved metabolic function. Tesofensine’s stimulation of the sympathetic nervous system boosts energy expenditure and metabolic rate, further supporting weight management efforts. The combined effects of appetite suppression, enhanced energy expenditure, and metabolic regulation make Tesofensine a promising pharmaceutical option for obese individuals seeking effective weight loss solutions and potential obesity treatment (3).

Antidepressant

While Tesofensine is primarily studied for weight loss, its impact on neurotransmitters like serotonin could potentially benefit individuals with depression. By inhibiting serotonin reuptake, Tesofensine increases serotonin levels in the brain, which may improve mood regulation and alleviate symptoms of depression (4).

Serotonin plays a crucial role in maintaining emotional well-being and is often targeted by antidepressant medications. Therefore, Tesofensine’s modulation of serotonin signaling could offer a dual benefit of weight management and mood enhancement for individuals suffering from both obesity and depression. Further research is needed to explore Tesofensine’s efficacy and safety in addressing depressive symptoms.